Understanding the factors influencing chronic inflammatory skin diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the variability in clinical expression and progression of chronic inflammatory skin diseases such as atopic dermatitis, psoriasis, eczema, lichen, and alopecia areata. By conducting long-term clinical assessments and analyzing individual biomaterials, the study seeks to identify clinical and molecular factors that correlate with disease subtypes and progression. The research will involve a larger cohort of patients to confirm preliminary findings from pilot studies regarding disease heterogeneity and its underlying mechanisms.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* dermatologist-diagnosed inflammatory skin disease
* informed consent

Exclusion Criteria:

* subject and/or the legal guardians are not able to give written informed consent
* pregnant and breastfeeding women
* concurrent participation in a clinical trial
* use of systemic immunosuppressive therapy or phototherapy during the last 4 weeks or receipt of biologics therapy (e.g. dupilumab, tralokinumab) within the last 3 months
* treatment of the target skin areas with topical corticosteroids, calcineurin inhibitors or emollients 24 hours before sample collection

Where it's running

• Department of Dermatology and Allergy, University Hospital Schleswig-Holstein
  Kiel, Germany Recruiting

Study contacts

• Study coordinator: Stephan Weidinger, MD
• Email: sweidinger@dermatology.uni-kiel.de
• Phone: 0049431500

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biomarkers that predict how skin-disease treatments will work

  Researchers are testing blood and skin markers to see if they can forecast which patients with inflammatory skin diseases will respond to systemic treatments over a year.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT06599411

• PALLAS 311 nm UVB laser treatment for vitiligo, psoriasis, alopecia areata, and atopic dermatitis

  This study will test the PALLAS 311 nm UVB laser as an in-clinic, twice-weekly treatment for adults with vitiligo, psoriasis, alopecia areata, or atopic dermatitis for up to three months.

  Recruiting Szeged University · Szeged, Csongrád-Csanád Vármegye · NCT07250997

• Abrocitinib for eczema and patchy hair loss in people with Down syndrome

  This trial will test whether taking abrocitinib daily can help improve eczema or patchy hair loss in people with Down syndrome aged 12 and up.

  Recruiting Phase 2 Icahn School of Medicine at Mount Sinai · New York, New York · NCT07242638

• New ceramide‑and‑coconut‑oil skin barrier cream versus petrolatum for dry or irritated skin

  This study will test whether a new ceramide- and coconut oil–based cream can improve skin hydration and reduce dryness and itch in adults with mild to moderate psoriasis, atopic dermatitis, contact dermatitis, or xerosis.

  Recruiting Makati Medical Center · Makati City, National Capital Region · NCT07183423

• Global assessment of disease burden in adolescents and adults with alopecia areata, vitiligo, or hidradenitis suppurativa

  This project will see if collecting real-world information from adolescents and adults with moderate or severe alopecia areata, non-segmental vitiligo, or hidradenitis suppurativa can describe their disease burden worldwide.

  Recruiting at 116 sites AbbVie · Ciudad Autonoma de Buenos Aire, Buenos Aires and 115 other locations · NCT07136467

• Evaluating full-body imaging technology for skin disease detection

  This study is testing a new full-body imaging technology to see if it can help doctors better detect and monitor skin diseases like skin cancer and eczema.

  Recruiting at 3 sites HJN Sverige AB/Neko Health · Stockholm and 2 other locations · NCT06989216

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.